Qube Research & Technologies Ltd

Position in MRVI — Maravai Lifesciences Holdings, Inc.

CIK 1729829 LONDON, X0

Position in MRVI

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,670,309

-$608,689 QoQ

Shares Held

748,447

-7.1% QoQ

Ownership

0.288%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#43

of 177 holders

Holding Since

Dec 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $2,443,042,063 across 169 Biotechnology names. MRVI ranks #79 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	798,715	$240,437,176
2	INSM	INSMED Inc	1,682,334	$179,370,451
3	REGN	Regeneron Pharmaceuticals, Inc.	221,607	$138,180,828
4	ROIV	Roivant Sciences Ltd.	3,454,496	$122,254,613
5	AXSM	Axsome Therapeutics, Inc.	426,336	$104,354,262
6	APGE	Apogee Therapeutics, Inc.	659,678	$87,559,060
7	TVTX	Travere Therapeutics, Inc.	1,443,230	$81,989,896
8	RPRX	Royalty Pharma plc	1,412,112	$79,177,119

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,670,309	748,447	-7.1%	Shares	Sole	2026-08-14
2023-12-31	$5,278,998	805,954	+796.2%	Shares	Sole	2024-02-13
2023-06-30	$1,117,879	89,934	-90.8%	Shares	Sole	2023-08-14
2023-03-31	$13,746,009	981,157	-20.6%	Shares	Sole	2023-05-15
2022-12-31	$17,674,066	1,235,085	+2257.0%	Shares	Sole	2023-02-14
2022-09-30	$1,337,797	52,401	+141.0%	Shares	Sole	2022-11-14
2022-06-30	$617,661	21,741	-33.2%	Shares	Sole	2022-08-15
2022-03-31	$1,148,250	32,556	-70.8%	Shares	Sole	2022-05-09
2021-12-31	$4,675,327	111,583	+154.7%	Shares	Sole	2022-02-10
2021-09-30	$2,150,145	43,809	+1.1%	Shares	Sole	2021-11-12
2021-06-30	$1,808,953	43,349	-7.4%	Shares	Sole	2021-08-13
2021-03-31	$1,669,235	46,836	+380.3%	Shares	Sole	2021-05-14
2020-12-31	$273,515	9,751	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.